Inhibikase Therapeutics Inc
Inhibikase Therapeutics Inc Stock, NASDAQ:IKT
Inhibikase Therapeutics, Inc. provides infectious disease treatments. It develops small molecule platform for treating both bacterial and viral infectious diseases. It operates through RAMPâ„¢ Drug Innovation Engine technology. The company was founded by Milton H. Werner in September 2008 and is headquartered in Atlanta, GA.